Snowball logo
logo
CTAB_logo

Canntab Therapeutics Limited

CTABF • PINK
$0.0001$0.00  (0%)
Estimate
EPS
-0.06
Beta
1.423
About the company
Ticker
CTABF
ISIN
Country
Canada
Sector (GICS)
Healthcare
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.

Frequently asked questions

What sector does Canntab Therapeutics Limited (CTABF) operate in?

Canntab Therapeutics Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Canntab Therapeutics Limited (CTABF) current stock price?

As of the latest data, Canntab Therapeutics Limited stock price is $0.00, with a previous close of $0.00.

What is Canntab Therapeutics Limited (CTABF) current market capitalization?

Canntab Therapeutics Limited market cap is approximately 3.89 thousand.

What is Canntab Therapeutics Limited (CTABF) Earnings Per Share (EPS)?

The trailing EPS is -$0.06.

Does Canntab Therapeutics Limited (CTABF) pay dividends?

No. Canntab Therapeutics Limited does not pay a dividend.

What is Canntab Therapeutics Limited (CTABF) beta (volatility) score?

Canntab Therapeutics Limited has a beta of 1.423, suggesting it is more volatile than the market.